组织芯片，组织微阵列

FDA800c	多器官多病理组织组合芯片，附病理分级、TNM和临床分期，72例/72点，替代FDA800b
点数	72	例数	72
行数	8	列数	9
点直径(mm)	1.5	厚度(µm)	5.0
组织阵列类型	石蜡包埋	种属	人类
QA/QC	H&E and IHC confirmed
Applications	Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes	1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better. 2.Bake the slides for 30 minutes at 60℃ before the experiment; 3.Please choose a gentle repair method to avoid tissue detachment.

Legend:

Per

-Peritoneum

Bon

-Bone

Pel

-Pelvic cavity

Sof

-Soft tissue

Abd

-Abdominal cavity

Ret

-Retroperitoneum

Abd

-Abdominal wall

Lym

-Lymph node

Spl

-Spleen

Kid

-Kidney

Bla

-Bladder

Cer

-Cerebellum

Bra

-Brain

Thy

-Thyroid

Med

-Mediastinum

Ova

-Ovary

Cer

-Cervix

Ute

-Uterus

Bre

-Breast

Liv

-Liver

Sto

-Stomach

Par

-Parotid gland

Ton

-Tongue

App

-Appendix

Eso

-Esophagus

Rec

-Rectum

Col

-Colon

Pan

-Pancreas

Sma

-Small intestine

Gal

-Gallbladder

Pro

-Prostate

Tes

-Testis

Lun

-Lung

Ski

-Skin

Benign (*)

Malignant (*)

Malignant (0.0)

Malignant (G1 IB)

Malignant (G2 IIA)

Malignant (G2 IIB)

Malignant (G3 IIA)

Malignant (G3 IIB)

Malignant (G3 III)

Malignant (G3 IIIB)

Malignant (I)

Malignant (IA)

Malignant (IB)

Malignant (II)

Malignant (IIA)

Malignant (IIB)

Malignant (III)

Malignant (IIIA)

Malignant (IIIB)

Malignant (IIIC)

Malignant (IV)

TISSUE ARRAYS FDA800c

	1	2	3	4	5	6	7	8	9
A	SKI	SKI	LUN	LUN	LUN	LUN	LUN	TES	TES
B	TES	PRO	PRO	GAL	GAL	SMA	SMA	PAN	PAN
C	COL	COL	REC	REC	REC	ESO	ESO	APP	TON
D	PAR	STO	LIV	LIV	BRE	BRE	BRE	BRE	UTE
E	UTE	UTE	UTE	CER	OVA	OVA	MED	THY	THY
F	BRA	BRA	BRA	BRA	CER	BLA	BLA	KID	KID
G	KID	LYM	LYM	LYM	SPL	LYM	SOF	SOF	RET
H	RET	ABD	RET	ABD	PEL	SOF	PEL	BON	PER

Pos	No	Age	Sex	Organ_Anatomic_Site	Pathology_diagnosis	Grade	TNM	Stage	Type	isBackUp
A1	1	55	M	Skin	Basal cell carcinoma of head	*	T2N0M0	II	Malignant	N
A2	2	46	M	Skin	Squamous cell carcinoma of left chest wall	2	T3N0M0	II	Malignant	N
A3	3	75	M	Lung	Small cell carcinoma	*	*	*	Malignant	N
A4	4	49	F	Lung	Adenocarcinoma	2--3	T2N1M0	IIB	Malignant	N
A5	5	45	M	Lung	Squamous cell carcinoma	3	T2N0M0	IB	Malignant	N
A6	6	60	F	Lung	Sarcomatoid carcinoma	*	T3N0M0	IIIB	Malignant	N
A7	7	62	F	Lung	Adenocarcinoma	2	T2N1M0	IIB	Malignant	N
A8	8	32	M	Testis	spermatocytoma	*	T1N0M0	IA	Malignant	N
A9	9	50	M	Testis	spermatocytoma	*	T1N0M0	IA	Malignant	N
B1	10	25	M	Testis	Embryonal carcinoma	*	T4N1M0	IIA	Malignant	N
B2	11	66	M	Prostate	Adenocarcinoma (Gleason grade:5; Gleason score:5+4)	3	T3aN0M0	III	Malignant	N
B3	12	64	M	Prostate	Pleomorphic rhabdomyosarcoma	*	T2bN0M0	G3 IIIB	Malignant	N
B4	13	64	F	Gallbladder	Adenocarcinoma	2	T2N1M0	III	Malignant	N
B5	14	76	M	Gallbladder	Adenosquamous carcinoma	*	T3N0M0	IIIA	Malignant	N
B6	15	35	F	Small intestine	Adenocarcinoma	2	T4N0M0	II	Malignant	N
B7	16	71	F	Small intestine	Malignant interstitialoma	*	T2N0M0	G2 IIB	Malignant	N
B8	17	64	M	Pancreas	Duct adenocarcinoma	2--3	T3N0M0	IIA	Malignant	N
B9	18	51	F	Pancreas	Islet cell carcinoma	*	*	*	Malignant	N
C1	19	67	M	Colon	Adenocarcinoma	3	T3N0M0	IIA	Malignant	N
C2	20	54	M	Colon	Malignant interstitialoma	*	T2N0M0	G2 IIB	Malignant	N
C3	21	60	M	Rectum	Adenocarcinoma	3	T3N1M0	II	Malignant	N
C4	22	48	M	Rectum	Low grade malignant interstitialoma	*	T2N0M0	G1 IB	Malignant	N
C5	23	54	F	Rectum	Malignant melanoma	*	T3N2M0	III	Malignant	N
C6	24	61	M	Esophagus	Squamous cell carcinoma	2	T2N0M0	IIA	Malignant	N
C7	25	68	M	Esophagus	Adenocarcinoma	3	T3N1M0	IIIA	Malignant	N
C8	26	50	F	Appendix	Adenocarcinoma	2	T1N0M0	I	Malignant	N
C9	27	78	M	Tongue	Squamous cell carcinoma	3	T2N0M0	II	Malignant	N
D1	28	72	F	Parotid gland	Adenoid cystic carcinoma	*	T2N0M0	II	Malignant	N
D2	29	57	M	Stomach	Mucinous adenocarcinoma	2--3	T4N1M0	IV	Malignant	N
D3	30	17	F	Liver	Embryonic hepatoblastoma	*	*	*	Malignant	N
D4	31	56	M	Liver	Hepatocellular carcinoma	3	T3N0M0	III	Malignant	N
D5	32	44	F	Breast	Ductal carcinoma in situ	*	TisN0M0	0.0	Malignant	N
D6	33	45	F	Breast	Carcinoma in situ	*	T2N1M0	IIB	Malignant	N
D7	34	38	F	Breast	Ductal carcinoma in situ	*	TisN0M0	0.0	Malignant	N
D8	35	47	F	Breast	Medullary carcinoma	*	T2N2M0	IIIA	Malignant	N
D9	36	48	F	Uterus	Endometrioid adenocarcinoma	2	T1bN0M0	IB	Malignant	N
E1	37	39	F	Uterus	Clear cell carcinoma	*	T2bN0M0	IIB	Malignant	N
E2	38	50	F	Uterus	Leiomyoma	*	*	*	Benign	N
E3	39	60	F	Uterus	Squamous cell carcinoma	3	T2N0M0	II	Malignant	N
E4	40	44	F	Cervix	Endocervical type adenocarcinoma	1	T1b1N0M0	IB	Malignant	N
E5	41	29	F	Ovary	Mucinous papillary carcinoma	2--3	T3N0M0	III	Malignant	N
E6	42	50	F	Ovary	High grade serous carcinoma	*	T3cN0M0	IIIC	Malignant	N
E7	43	61	M	Mediastinum	Thymoma (type B3)	*	T1N0M0	I	Malignant	N
E8	44	33	F	Thyroid	Medullary carcinoma	*	T3N0M0	II	Malignant	N
E9	45	45	F	Thyroid	Papillary carcinoma	*	T2N1M0	III	Malignant	N
F1	46	65	F	Brain	Atypical meningioma	*	*	*	Malignant	N
F2	47	15	F	Brain	Malignant ependymoma of right occipital lobe	*	*	*	Malignant	N
F3	48	41	M	Brain	Anaplastic oligodendroglioma	3	*	*	Malignant	N
F4	49	59	M	Brain	Glioblastoma	4	*	*	Malignant	N
F5	50	27	F	Cerebellum	Medulloblastoma	*	*	*	Malignant	N
F6	51	65	M	Bladder	High grade urothelial carcinoma with phosphatization	*	T3N0M0	III	Malignant	N
F7	52	62	M	Bladder	Leiomyosarcoma	*	T2bN0M0	G1 IB	Malignant	N
F8	53	66	M	Kidney	High grade urothelial carcinoma	*	T1N0M0	I	Malignant	N
F9	54	57	F	Kidney	Papillary renal cell carcinoma	*	T2N0M0	II	Malignant	N
G1	55	63	F	Kidney	Clear cell carcinoma	*	*	*	Malignant	N
G2	56	53	F	Lymph node	Diffuse B-cell lymphoma of neck	*	*	*	Malignant	N
G3	57	50	F	Lymph node	Diffuse B-cell lymphoma of right thigh	*	*	*	Malignant	N
G4	58	37	M	Lymph node	Diffuse B-cell lymphoma of left groin	*	*	*	Malignant	N
G5	59	21	M	Spleen	Diffuse B-cell lymphoma	*	*	*	Malignant	N
G6	60	40	M	Lymph node	Hodgkin's lymphoma of left neck	*	*	*	Malignant	N
G7	61	78	M	Soft tissue	Moderate malignant leiomyosarcoma of chest wall	*	T1aN0M0	G2 IIA	Malignant	N
G8	62	20	F	Soft tissue	Embryonal rhabdomyosarcoma of left leg	*	T1aN0M0	G3 IIA	Malignant	N
G9	63	48	F	Retroperitoneum	Pleomorphic rhabdomyosarcoma	*	T2N0M0	G3 IIB	Malignant	N
H1	64	14	F	Retroperitoneum	Primitive neuroectodermal tumor	*	T2N0M0	IIIB	Malignant	N
H2	65	44	M	Abdominal wall	Clear cell sarcoma	*	T2N0M0	G3 IIIB	Malignant	N
H3	66	18	M	Retroperitoneum	Neuroblastoma	*	*	*	Malignant	N
H4	67	48	F	Abdominal cavity	Mucinous liposarcoma	*	T2bN0M0	G3 III	Malignant	N
H5	68	56	M	Pelvic cavity	Chordoma	*	*	*	Malignant	N
H6	69	21	M	Soft tissue	Neurofibroma of back	*	*	*	Malignant	N
H7	70	40	M	Pelvic cavity	Synovial sarcoma of right chest wall	*	T2bN0M0	IIB	Malignant	N
H8	71	7	F	Bone	Osteosarcoma of right femur	*	T2N0M0	G3 IIB	Malignant	N
H9	72	33	M	Peritoneum	Epithelial malignant mesothelioma	*	*	*	Malignant	N